Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-06-001688
Filing Date
2006-03-20
Accepted
2006-03-20 16:32:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 d652946_13g.txt SC 13G 10086
  Complete submission text file 0000919574-06-001688.txt   11900
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 1010017
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10017 2128082400
CURRAN JOHN P (Filed by) CIK: 0000026256 (see all company filings)

Type: SC 13G

Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Subject) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-40470 | Film No.: 06698978
SIC: 2834 Pharmaceutical Preparations